Table 3.
Ethnicity | African Americans | Chinese, CA | Japanese, JA | Caucasian, NHW | Hispanic |
---|---|---|---|---|---|
DHAS (ug/dL) | 0.47 (−92.8–178.8) | −13.80 (−188.3–201.9) | − 0.94 (− 149.1–129.6) | 1.24 (−170.9–227.6) | −23.21 (− 200.5–80.7) |
DHAS (%) | 8.55 (−68.7–444.8) | 4.85 (− 81.6–604.7) | 8.66 (− 64.7–291.7) | 9.86 (− 82.4–250.9) | 0.20 (− 78.9–130.8) |
FSH (mIU/mL) | 27.86* (−93.0–181.8) | 29.51* (− 102.8–188.7) | 44.91* (− 47.6–225.3) | 39.61* (− 78.7–185.3) | 5.39* (−26.3–79.4) |
FSH (%) | 157.77 (−84.0–1986.1) | 145.00 (− 72.4–1238.0) | 224.19 (−65.8–5364.3) | 184.59 (−89.1–2404.7) | 114.75 (−54.9–680.0) |
SHBG (nM) | 1.63 (− 109.6–149.9) | 7.33 (− 98.8–145.9) | 9.08 (− 117.6–108.9) | 4.81 (− 97.2–137.5) | 6.45 (− 34.9–38.4) |
SHBG (%) | 51.51 (−76.9–3848.0) | 53.10 (− 76.77–782.14) | 37.31 (− 68.8–414.7) | 26.88 (− 81.4–670.7) | 21.15 (− 38.0–107.6) |
T (ng/dL) | 15.97* (−27.7–226.8) | 3.00* (− 35.3–62.1) | 4.10* (− 45.4–67.0) | 3.54* (− 52.5–129.6) | 18.89* (− 14.8–81.4) |
T (%) | 61.51* (−87.1–704.4) | 9.81* (− 79.2–149.4) | 24.57* (− 59.0–259.1) | 26.24* (− 85.7–664.2) | 113.83* (− 52.9–767.9) |
E2 (pg/mL) | − 29.29 (− 483.2–240.0) | −21.16 (353.8–1158.3) | −35.94 (− 723.8–549.6) | −45.42 (− 531.0–195.4) | −40.38 (− 340.0–22.2) |
E2 (%) | 29.05 (− 94.9–3000.6) | 25.12 (− 97.6–1421.5) | −0.54 (− 99.2–2224.9) | −7.24 (− 98.05–962.56) | −4.77 (− 94.5–223.6) |
Abbreviations: SWAN Study of Women’s Health Across the Nation; DHAS dehydroepiandrosteronesulphate; FSH follicle-stimulating hormone; SHBG sex-hormone binding globulin; T testosterone; E2 estradiol; CA Chinese-American; JA Japanese-American; NHW Non-Hispanic Whites. The values are from SWAN baseline to visit 10; values in parentheses are range: the first dash means a decrease in the level of the hormone; the second dash is for range. * represents significant difference (P < 0.05); For sample size see Table 1